This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn’t tell regulators about safety problems with an infamous drug, marketed other medicines for uses for which they were not approved and might not have been safe, and took various steps that may have increased the amount of medicine it sold and the price of that medicine in ways that were not legal.
